Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Colgate-Palmolive (CL) Q3 Earnings In Line, '16 View Intact

Published 10/27/2016, 07:32 AM
Updated 07/09/2023, 06:31 AM

Colgate-Palmolive Co. (NYSE:CL) , a global dealer in consumer goods, came out with third-quarter 2016 adjusted earnings of 73 cents per share, in line with the Zacks Consensus Estimate and up 1% year over year. Including one-time items, the company’s earnings of 78 cents per share were down 2.5% year over year.

For 2016, the company now projects adjusted earnings per share to remain flat year over year. However, GAAP earnings per share are expected to increase in the high double-digit range.

Earnings Estimate Revision: The Zacks Consensus Estimate for 2016 has been stable over the past 30 days. If we look at Colgate’s performance in the trailing four quarters (including the quarter under review), the company has outperformed the Zacks Consensus Estimate by an average of 0.71%.

COLGATE PALMOLI Price, Consensus and EPS Surprise

COLGATE PALMOLI Price, Consensus and EPS Surprise | COLGATE PALMOLI Quote

Revenues: Colgate’s global sales declined 3.3% to $3,867 million during the quarter, as benefit from 3% rise in prices was more than offset by a 4% fall in volumes and 2.5% negative impact of from currency fluctuations. Quarterly revenues were also short of the Zacks Consensus Estimate of $3,932 million. Organic sales rose 4.5% during the quarter.

Despite tough macroeconomic environment and foreign currency headwinds, management anticipates robust organic sales growth in 2016 buoyed by new product pipeline across all categories and regions. However, net sales for 2016 are expected to decline in the low to mid-single-digit range, due to the persistence of currency headwinds.

Zacks Rank: Currently, Colgate carries a Zacks Rank #3 (Hold) which is subject to change based on the just released earnings results. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Check back later for our full write up on Colgate’s earnings report!

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


COLGATE PALMOLI (CL): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.